MiNK Therapeutics, Inc. (INKT) Tops Q4 EPS by 44c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of $0.23, $0.44 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Elastic N.V. (ESTC) Tops Q1 EPS by 12c, Beats on Revenue; offers FY27 Guidance
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79